https://www.marketscreener.com/quote/stock/ONCOMED-PHARMACEUTICALS-I-13644077/news/Oncomed-Pharmaceuticals-Doses-First-Patient-in-Phase-1b-Portion-of-anti-TIGIT-Clinical-Trial-26754672/?utm_source=telegram&utm_medium=social&utm_campaign=share